A 58-year-old man undergoes TRUS-guided prostate biopsy for elevated PSA and abnormal DRE. Histopathology shows adenocarcinoma with a Gleason score of 7 (3+4). Which investigation is most appropriate for assessing local staging and determining candidacy for nerve-sparing radical prostatectomy?

Explanation

## Investigation of Choice for Local Staging of Prostate Cancer **Key Point:** Multiparametric MRI (mpMRI) with endorectal coil is the gold standard for local staging of prostate cancer, assessing capsular integrity, seminal vesicle invasion, and extraprostatic extension—critical for surgical planning. ### Clinical Context This patient has: - Biopsy-confirmed adenocarcinoma (Gleason 7 = intermediate risk) - Need for local staging to guide treatment (surgery vs. radiation vs. active surveillance) - Candidate assessment for nerve-sparing prostatectomy ### Why mpMRI with Endorectal Coil? | Parameter | mpMRI + Endorectal Coil | Other Modalities | |-----------|-------------------------|------------------| | **Capsular assessment** | Excellent (T-stage accuracy 85–90%) | TRUS: operator-dependent, lower accuracy | | **Seminal vesicle invasion** | High sensitivity (>90%) | Bone scan: assesses bone only, not local | | **Extraprostatic extension** | Detects >5 mm extension reliably | Ultrasound: poor soft-tissue contrast | | **Nerve bundle visualization** | Allows nerve-sparing planning | Cannot assess neurovascular bundle | | **Metastatic disease** | Limited field; use separate staging CT | Bone scan: for osseous metastases | | **Timing** | Perform AFTER biopsy diagnosis | TRUS: diagnostic tool, not staging | **High-Yield:** mpMRI is recommended by NCCN and EAU guidelines for intermediate-to-high-risk prostate cancer (Gleason ≥7) to guide treatment selection and surgical planning. ### Staging Hierarchy in Prostate Cancer ```mermaid flowchart TD A[Biopsy-confirmed PCa]:::outcome --> B{Risk stratification}:::decision B -->|Low risk| C[PSA, DRE follow-up]:::action B -->|Intermediate-High risk| D[mpMRI + Endorectal coil]:::action D --> E{Local extent?}:::decision E -->|Organ-confined| F[Consider nerve-sparing RP]:::action E -->|ECE/SVI| G[Neoadjuvant therapy ± RP]:::action B -->|Any risk| H[Bone scan if PSA >20 or symptoms]:::action D --> I[Assess for distant mets on staging CT]:::action ``` ### Role of Other Investigations 1. **Bone scan (Tc-99m)** — Used for: - Detecting skeletal metastases - Indicated when PSA >20 ng/mL or high-risk features - NOT for local staging 2. **Pelvic ultrasound** — Limited role: - Poor soft-tissue resolution - Cannot reliably assess capsular invasion or SVI - Operator-dependent 3. **TRUS without biopsy** — Not appropriate: - Diagnostic tool, not staging tool - Lower accuracy for T-stage assessment vs. mpMRI **Clinical Pearl:** Endorectal coil MRI provides superior signal-to-noise ratio compared to body coil alone, improving visualization of the prostate capsule and neurovascular bundles—essential for surgical planning. **Mnemonic: mpMRI for LOCAL staging** — **L**ocal extent, **O**rgan-confined vs. extraprostatic, **C**apsular integrity, **A**ssess seminal vesicles, **L**aunch treatment planning. [cite:Robbins 10e Ch 21]